Efficacy and safety of flexible and navigable suction ureteral access sheath combined with flexible ureteroscopic lithotripsy versus flexible ureteroscopic lithotripsy alone for infected upper urinary tract stones: a retrospective cohort study - Scorecard - MDSpire
Advertisement
Efficacy and safety of flexible and navigable suction ureteral access sheath combined with flexible ureteroscopic lithotripsy versus flexible ureteroscopic lithotripsy alone for infected upper urinary tract stones: a retrospective cohort study
Clinical Scorecard: Comparative Analysis of the Effectiveness and Safety of a Flexible Navigable Suction Ureteral Access Sheath with Flexible Ureteroscopic Lithotripsy Versus Flexible Ureteroscopic Lithotripsy Alone for Treating Infected Upper Urinary Tract Stones: A Retrospective Cohort Investigation
At a Glance
Category
Detail
Condition
Infected upper urinary tract stones (renal and ureteral stones with infection)
Key Mechanisms
Stone formation associated with urease-producing bacteria causing rapid growth, staghorn formations, recurrence, and severe complications including urinary tract infections and systemic inflammatory response
Target Population
Patients with infected upper urinary tract stones confirmed by CT and stone composition analysis, ASA physical status I-II
Care Setting
Urological surgical care in hospital setting with preoperative evaluation and perioperative antibiotic management
Key Highlights
Infected stones constitute approximately 15% of urinary tract stones and are characterized by rapid growth and high complication risk.
Flexible ureteroscopic lithotripsy (FURL) combined with flexible navigable suction ureteral access sheath (FANS-UAS) enhances stone clearance by reducing intrarenal pressure and facilitating removal of powdered stone fragments.
Retrospective cohort study comparing FURL alone versus FURL combined with FANS-UAS showed potential improvements in efficacy and safety for infected upper urinary tract stones.
Guideline-Based Recommendations
Diagnosis
Preoperative CT imaging for precise stone localization and characterization.
Stone composition analysis confirming struvite or carbonate apatite to identify infected stones.
Urine culture and urinalysis to guide antibiotic therapy.
Management
Complete stone eradication combined with antibiotic therapy is essential.
Preoperative infection control with antibiotics based on culture sensitivity or empirical therapy if indicated.
Flexible ureteroscopic lithotripsy (FURL) with or without FANS-UAS as surgical options, with FANS-UAS facilitating improved stone fragment removal.
Prophylactic antibiotics administered one hour before surgery.
Monitoring & Follow-up
Preoperative laboratory tests including leukocytes, hemoglobin, urine culture, liver and kidney function, and coagulation profiles.
Postoperative monitoring for infection control and complications.
Risks
Potential for systemic inflammatory response syndrome (SIRS) and sepsis if bacteria enter circulation.
Surgical risks associated with stone removal procedures.
Need for careful patient selection excluding those with severe comorbidities or active systemic infection.
Patient & Prescribing Data
Patients with infected upper urinary tract stones undergoing surgical treatment with FURL or FURL combined with FANS-UAS.
Antibiotic therapy tailored to urine culture results is critical; prophylactic antibiotics reduce perioperative infection risk; FANS-UAS may improve stone clearance and reduce intrarenal pressure during lithotripsy.
Clinical Best Practices
Ensure thorough preoperative evaluation including imaging and laboratory testing to confirm stone infection and patient suitability.
Administer targeted antibiotic therapy preoperatively until infection is controlled before surgery.
Use FURL combined with FANS-UAS to enhance stone fragment removal and reduce intrarenal pressure during surgery.
Follow strict perioperative anti-infective protocols aligned with national guidelines.
Exclude patients with severe comorbidities or active systemic infections to minimize surgical risks.